Annual Total Long Term Liabilities
$0.00
-$64.00 K-100.00%
31 December 2023
Summary:
GT Biopharma annual total long term liabilities is currently $0.00, with the most recent change of -$64.00 thousand (-100.00%) on 31 December 2023. During the last 3 years, it has risen by $0.00 (0.00%). GTBP annual total long term liabilities is now -100.00% below its all-time high of $1.60 million, reached on 31 December 1998.GTBP Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$0.00
$0.000.00%
30 September 2024
Summary:
GT Biopharma quarterly total long term liabilities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has dropped by -$1.05 million (-100.00%). GTBP quarterly long term liabilities is now -100.00% below its all-time high of $2.96 million, reached on 31 March 2023.GTBP Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTBP Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | -100.0% |
| 3 y3 years | 0.0% | 0.0% |
| 5 y5 years | 0.0% | 0.0% |
GTBP Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | -100.0% | ||
| 5 y | 5 years | -100.0% | -100.0% | ||
| alltime | all time | -100.0% | +100.0% | -100.0% | +100.0% |
GT Biopharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $0.00(0.0%) |
| June 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2023 | - | $1.05 M(-31.5%) |
| June 2023 | - | $1.54 M(-48.0%) |
| Mar 2023 | - | $2.96 M(+4520.3%) |
| Dec 2022 | $64.00 K(>+9900.0%) | $64.00 K(-30.4%) |
| Sept 2022 | - | $92.00 K(-23.3%) |
| June 2022 | - | $120.00 K(-18.4%) |
| Mar 2022 | - | $147.00 K(>+9900.0%) |
| Dec 2021 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2021 | - | $0.00(0.0%) |
| June 2021 | - | $0.00(0.0%) |
| Mar 2021 | - | $0.00(0.0%) |
| Dec 2020 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2020 | - | $0.00(0.0%) |
| June 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00(0.0%) |
| Dec 2019 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2019 | - | $0.00(0.0%) |
| June 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2018 | - | $0.00(0.0%) |
| June 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2016 | - | $400.00 K(-24.2%) |
| June 2016 | - | $528.00 K(-4.5%) |
| Mar 2016 | - | $553.00 K(-22.5%) |
| Dec 2015 | $714.00 K(+12.6%) | $714.00 K(-68.8%) |
| Sept 2015 | - | $2.29 M(+57.8%) |
| June 2015 | - | $1.45 M(+70.9%) |
| Mar 2015 | - | $849.00 K(+33.9%) |
| Dec 2014 | $634.00 K(+553.6%) | $634.00 K(+107.2%) |
| Sept 2014 | - | $306.00 K(+96.2%) |
| June 2014 | - | $156.00 K(+21.9%) |
| Mar 2014 | - | $128.00 K(+32.0%) |
| Dec 2013 | $97.00 K(>+9900.0%) | $97.00 K(>+9900.0%) |
| Sept 2013 | - | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2012 | - | $0.00(0.0%) |
| June 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2011 | - | $0.00(0.0%) |
| June 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2010 | - | $404.00 K(0.0%) |
| June 2010 | - | $404.00 K(-18.5%) |
| Mar 2010 | - | $496.00 K(+99.2%) |
| Dec 2009 | $249.00 K(>+9900.0%) | $249.00 K(>+9900.0%) |
| Sept 2009 | - | $0.00(0.0%) |
| June 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2008 | - | $25.00 K(0.0%) |
| Dec 2007 | $25.00 K(-83.2%) | $25.00 K(-96.2%) |
| Sept 2007 | - | $653.00 K(+35.2%) |
| June 2007 | - | $483.00 K(+53.3%) |
| Mar 2007 | - | $315.00 K(+111.4%) |
| Dec 2006 | $149.00 K(+263.4%) | $149.00 K(+263.4%) |
| Sept 2006 | - | $41.00 K(0.0%) |
| June 2006 | - | $41.00 K(0.0%) |
| Mar 2006 | - | $41.00 K(0.0%) |
| Dec 2005 | $41.00 K(+1950.0%) | $41.00 K(+1950.0%) |
| Dec 2001 | $2000.00(-98.7%) | $2000.00(+100.0%) |
| Sept 2001 | - | $1000.00(-99.4%) |
| June 2001 | - | $156.00 K(+9.1%) |
| Mar 2001 | - | $143.00 K(-4.7%) |
| Dec 2000 | $150.00 K(-22.7%) | $150.00 K(-6.3%) |
| Sept 2000 | - | $160.00 K(-4.8%) |
| June 2000 | - | $168.00 K(-10.6%) |
| Mar 2000 | - | $188.00 K(-3.1%) |
| Dec 1999 | $194.00 K(-87.9%) | $194.00 K(+94.0%) |
| Sept 1999 | - | $100.00 K(-50.0%) |
| June 1999 | - | $200.00 K(0.0%) |
| Mar 1999 | - | $200.00 K(-87.5%) |
| Dec 1998 | $1.60 M(+6.9%) | $1.60 M(-5.6%) |
| Sept 1998 | - | $1.70 M(0.0%) |
| June 1998 | - | $1.70 M(0.0%) |
| Mar 1998 | - | $1.70 M(+13.3%) |
| Dec 1997 | $1.50 M(+7.1%) | $1.50 M(+1400.0%) |
| Sept 1997 | - | $100.00 K(-92.3%) |
| Mar 1996 | - | $1.30 M(-7.1%) |
| Dec 1995 | $1.40 M(+250.0%) | $1.40 M(+250.0%) |
| Sept 1995 | - | $400.00 K(-20.0%) |
| June 1995 | - | $500.00 K(+66.7%) |
| Mar 1995 | - | $300.00 K(-25.0%) |
| Dec 1994 | $400.00 K(-500.0%) | $400.00 K(-33.3%) |
| Sept 1994 | - | $600.00 K(-700.0%) |
| Sept 1993 | - | -$100.00 K(0.0%) |
| Mar 1992 | - | -$100.00 K(0.0%) |
| Dec 1986 | -$100.00 K | -$100.00 K |
FAQ
- What is GT Biopharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for GT Biopharma?
- What is GT Biopharma annual total long term liabilities year-on-year change?
- What is GT Biopharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for GT Biopharma?
- What is GT Biopharma quarterly long term liabilities year-on-year change?
What is GT Biopharma annual total long term liabilities?
The current annual total long term liabilities of GTBP is $0.00
What is the all time high annual total long term liabilities for GT Biopharma?
GT Biopharma all-time high annual total long term liabilities is $1.60 M
What is GT Biopharma annual total long term liabilities year-on-year change?
Over the past year, GTBP annual total long term liabilities has changed by -$64.00 K (-100.00%)
What is GT Biopharma quarterly total long term liabilities?
The current quarterly long term liabilities of GTBP is $0.00
What is the all time high quarterly long term liabilities for GT Biopharma?
GT Biopharma all-time high quarterly total long term liabilities is $2.96 M
What is GT Biopharma quarterly long term liabilities year-on-year change?
Over the past year, GTBP quarterly total long term liabilities has changed by -$1.05 M (-100.00%)